SMAD5 downregulation inhibited cell proliferation, invasion and migration, and reversed EMT, enhanced apoptosis of nasopharyngeal carcinoma cells [28], which is consistent with our study. The gene discussed is SMAD5; the disease is nasopharyngeal carcinoma.